InvestorsHub Logo
Followers 138
Posts 22872
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Saturday, 01/28/2017 12:02:47 PM

Saturday, January 28, 2017 12:02:47 PM

Post# of 807
Medimmune's MEDI0641, a novel antibody-drug conjugate targeted to 5T4

https://onctoday.com/recent-abstracts/other-cancers/head-neck/26889-5t4-targeted-therapy-ablates-cancer-stem-cells-and-prevents-recurrence-of-head-and-neck-squamous-cell-carcinoma.html

Collectively, these findings demonstrate that an anti-5T4 antibody-drug conjugate reduces the fraction of cancer stem cells and prevents local recurrence, and suggest a novel therapeutic approach for patients with HNSCC.



Good luck and GOD bless,

George